Medication info

Empagliflozin 10 mg (Empagliflozin)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Keeps Biopharma Co., Ltd.
Appearance
Yellowish-colored, bilaterally convex, round, film-coated tablets
Packaging
10 tablets/box [10 tablets/PTP*1], 30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202102034 · Approved 2021.03.04

This product's status changed to Approval withdrawn on 2025.03.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], adjust or maintain the dose at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Ingredients

Manufacturer
Keeps Biopharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty controlling blood sugar
  • inability to control blood sugar
  • cardiovascular disease
  • occurrence of cardiovascular events
View approved original text

This medication is used to improve blood sugar control in adults with type 2 diabetes and serves as an adjunct to diet and exercise. It can be used alone when blood sugar control is difficult and may be combined with medications such as metformin, pioglitazone, sulfonylureas, insulin, or the DPP-4 inhibitor linagliptin, as needed. It plays an important role in blood sugar control, particularly for patients with cardiovascular disease, thus should be used with caution according to expert guidance. This medication is used to enhance blood sugar control and assist in diabetes management.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], adjust or maintain the dose at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Precautions

This medication should not be used by patients with allergic reactions to the active ingredient or other components. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. It is not suitable for patients with severely impaired kidney function, end-stage renal disease, or undergoing dialysis. Due to the presence of lactose in this medication, patients with genetic issues such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should also avoid taking it. Patients with mildly impaired kidney function should use this medication cautiously, and dosage adjustments or discontinuation may be needed based on kidney function. Patients with mild to moderate heart failure should use it carefully, and it is not recommended for patients with severe heart failure. When taken concurrently with medications such as insulin or sulfonylureas, there may be a risk of hypoglycemia, so dose adjustments may be necessary. Patients should be cautious of side effects such as hypoglycemia, genital infections, urinary tract infections, increased urination, and fluid volume depletion while taking this medication. Particularly, elderly patients or those at risk of fluid volume depletion should be vigilant for dehydration or hypotension, and regular monitoring of kidney function is required. This medication can cause a serious metabolic disturbance known as ketoacidosis, so any related symptoms should be promptly discussed with healthcare professionals. Pregnant women should avoid using this medication, and it should also be avoided during breastfeeding. Caution is needed during driving or operating machinery due to the risk of hypoglycemia while taking this medication. No specific toxic symptoms are known in the case of overdose, but appropriate treatment may be required based on clinical status. This medication has not been established as safe or effective for use in children and adolescents, so it should not be administered to them. When storing this medication, it should be kept out of the reach of children and should not be transferred to other containers.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitiss
  • other genital infections
  • urinary tract infection
  • perineal gangrene
  • itching
  • rash
  • urticaria
Show 211 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • adnexal abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral calculi
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • cavities
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • enteritis
  • flatulence
  • gastric polyps
  • gingival swelling
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • dental pain
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • paronychia
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • position-related dizziness
  • sensory impairment
  • perceptual disturbances
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory disorders
  • drowsiness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • abnormal electrocardiogram
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • kidney mass
  • urinary retention
  • urinary tract pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • prickly heat
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival injection
  • eyelid swelling
  • visual impairment
  • floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular disorders
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • insomnia
  • acute cholecystitis
  • hepatitis
  • otalgia
  • position-related vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid mass
  • constipation
  • vulvar pruritus
  • genital pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius to ensure the medication remains effective and safe to use.

Appearance and packaging

Appearance

Yellowish-colored, bilaterally convex, round, film-coated tablets

Package unit

10 tablets/box [10 tablets/PTP*1], 30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.